| scholarly article | Q13442814 |
| P2093 | author name string | Kim YS | |
| Itzkowitz SH | |||
| Montgomery CK | |||
| Yuan M | |||
| Bigbee WL | |||
| Kjeldsen T | |||
| Takahashi HK | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 197-204 | |
| P577 | publication date | 1989-01-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer | |
| P478 | volume | 49 |
| Q91817308 | A Graphene-Based Glycan Biosensor for Electrochemical Label-Free Detection of a Tumor-Associated Antibody |
| Q39340190 | A Tn antigen binding lectin from Myrsine coriacea displays toxicity in human cancer cell lines |
| Q37380026 | A new model for the presentation of tumor-associated antigens and the quest for an anticancer vaccine: a solution to the synthesis challenge via ring-closing metathesis |
| Q54361569 | A rat model to study the role of STn antigen in colon cancer. |
| Q89589976 | Aberrant O-glycosylation contributes to tumorigenesis in human colorectal cancer |
| Q59337421 | Aberrant glycosylation in colorectal cancer with genomic and epigenomic alterations |
| Q90248415 | Activation of the C-Type Lectin MGL by Terminal GalNAc Ligands Reduces the Glycolytic Activity of Human Dendritic Cells |
| Q37738102 | Aided Diagnosis of Hepatocellular Carcinoma Using Serum Fucosylated Haptoglobin Ratios |
| Q46582314 | Alkali-catalyzed beta-elimination of periodate-oxidized glycans: a novel method of chemical deglycosylation of mucin gene products in paraffin embedded sections |
| Q90114767 | Altered glycosylation associated with dedifferentiation of hepatocellular carcinoma: a lectin microarray-based study |
| Q37581540 | Altered tumor-cell glycosylation promotes metastasis |
| Q33795210 | Analysis of Recombinant CD24 Glycans by MALDI-TOF-MS Reveals Prevalence of Sialyl-T Antigen |
| Q36647324 | Anti-lymphocyte autoantibodies in systemic lupus erythematosus. |
| Q37375709 | Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein |
| Q41621723 | Application of chemically desialylated and degalactosylated human glycophorin for induction and characterization of anti-Tn monoclonal antibodies |
| Q89148025 | Augmenting Vaccine Immunogenicity through the Use of Natural Human Anti-rhamnose Antibodies |
| Q77900861 | Biology of colorectal cancer in ulcerative colitis |
| Q41437351 | Biosynthesis and secretion of mucin-related products in Hs746T gastric cancer cells |
| Q35525289 | Cancer vaccines and carbohydrate epitopes |
| Q52842975 | Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis. |
| Q34970766 | Cell surface glycan alterations in epithelial mesenchymal transition process of Huh7 hepatocellular carcinoma cell |
| Q37845669 | Cell surface markers in colorectal cancer prognosis |
| Q26798183 | Challenges in Antibody Development against Tn and Sialyl-Tn Antigens |
| Q35975732 | Characterisation and clinical usefulness of CA130 antigen recognised by monoclonal antibodies, 130-22 and 145-9, in ovarian cancers |
| Q78757823 | Clinicopathologic evaluation of CDw75 antigen expression in colorectal adenocarcinomas |
| Q41465858 | Coexpression of cancer-associated carbohydrate antigens, Tn and sialyl Tn. |
| Q53270597 | Colonic carcinogenesis along different genetic routes: glycophenotyping of tumor cases separated by microsatellite instability/stability. |
| Q35978076 | Combined evaluation of preoperative serum sialyl-Tn antigen and carcinoembryonic antigen levels is prognostic for gastric cancer patients |
| Q41727230 | Comparative studies on expression of tumor-associated antigens in human and induced pancreatic cancer in Syrian hamsters. |
| Q38353376 | Correlation between the sialylation of cell surface Thomsen-Friedenreich antigen and the metastatic potential of colon carcinoma cells in a mouse model. |
| Q92645662 | Correlation of Tn antigen expression with mucins in Chinese patients with colorectal cancer |
| Q36403882 | Designer glycopeptides for cytotoxic T cell-based elimination of carcinomas |
| Q71942323 | Detection of Tn, sialosyl-Tn and T antigens in hereditary nonpolyposis colorectal cancer |
| Q27322613 | Detection of colorectal dysplasia using fluorescently labelled lectins. |
| Q58493588 | Detection of the MUC2 apomucin tandem repeat with a mouse monoclonal antibody |
| Q40462066 | Diagnostic value of lectins in differentiation of molar placentas. |
| Q93002889 | Different isolation approaches lead to diverse glycosylated extracellular vesicle populations |
| Q53435760 | Different modes of sialyl-Tn expression during malignant transformation of human colonic mucosa. |
| Q58774191 | Differential expression of Cosmc, T-synthase and mucins in Tn-positive colorectal cancers |
| Q37225998 | Differential expression of the cancer associated antigens T (Thomsen-Friedenreich) and Tn to the skin in primary and metastatic carcinomas |
| Q38299042 | Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin |
| Q41683514 | Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium |
| Q72239442 | Distribution of Tn antigen recognized by an anti-Tn monoclonal antibody (MLS128) in normal and malignant tissues of the digestive tract |
| Q49185043 | Drug resistance related to aberrant glycosylation in colorectal cancer |
| Q37222147 | Effective antitumor therapy based on a novel antibody-drug conjugate targeting the Tn carbohydrate antigen |
| Q40982361 | Enzymatic basis for sialyl-Tn expression in human colon cancer cells |
| Q92063533 | Esophageal, gastric and colorectal cancers: Looking beyond classical serological biomarkers towards glycoproteomics-assisted precision oncology |
| Q35084954 | Establishment of new predictive markers for distant recurrence of colorectal cancer using lectin microarray analysis. |
| Q35831480 | Expression of alpha 2,6-linked sialic acid residues in neoplastic but not in normal human colonic mucosa. A lectin-gold cytochemical study with Sambucus nigra and Maackia amurensis lectins |
| Q41852370 | Expression of blood group antigens H-2, Le(y), and sialylated-Le(a) in human colorectal carcinoma. An immunohistochemical study using double-labeling techniques |
| Q55314511 | Expression of mucin carbohydrates and core proteins in carcinomas of the ampulla of Vater: their relationship to prognosis. |
| Q72317046 | Expression of sialosyl-Tn antigen (monoclonal antibody MLS102 reactive) in normal tissues and malignant tumors of the digestive tract |
| Q34207920 | Expression of sialyl-Tn antigen in breast cancer cells transfected with the human CMP-Neu5Ac: GalNAc alpha2,6-sialyltransferase (ST6GalNac I) cDNA. |
| Q36261936 | Expression profile of mucin-associated sialyl-Tn antigen in Chinese patients with different colorectal lesions (adenomas, carcinomas). |
| Q26750872 | Glycomic Approaches for the Discovery of Targets in Gastrointestinal Cancer |
| Q36742398 | Glycoprotein disease markers and single protein-omics |
| Q30658777 | Glycosylations versus conformational preferences of cancer associated mucin core |
| Q42339288 | Hyperglycemia exacerbates colon cancer malignancy through hexosamine biosynthetic pathway |
| Q37295526 | Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation. |
| Q70577158 | Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant |
| Q53501931 | Immunodetection of sialyl-Tn antigen in normal, hyperplastic and cancerous tissues of the uterine endometrium. |
| Q71729275 | Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients |
| Q40008948 | Immunohistochemical examination of anti-STn monoclonal antibodies LLU9B4, B72.3, and B35.2 for their potential use as tumor markers |
| Q71729264 | Immunoscintigraphy of colorectal cancer using 111In-labeled monoclonal antibody to mucin |
| Q36382475 | In vivo analysis of cadherin function in the mouse intestinal epithelium: essential roles in adhesion, maintenance of differentiation, and regulation of programmed cell death |
| Q34808316 | Induction of cyclooxygenase-2 in monocyte/macrophage by mucins secreted from colon cancer cells. |
| Q41402020 | Inhibition of mucin synthesis by benzyl-α-GalNAc in KATO III gastric cancer and Caco-2 colon cancer cells |
| Q26769924 | MGL Receptor and Immunity: When the Ligand Can Make the Difference |
| Q36413436 | MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients. |
| Q40341956 | MUC-2 human small intestinal mucin gene structure. Repeated arrays and polymorphism |
| Q38570769 | MUC1 (CD227): a multi-tasked molecule |
| Q90660454 | Metastasis of cholangiocarcinoma is promoted by extended high-mannose glycans |
| Q60917045 | Morniga-G, a T/Tn-Specific Lectin, Induces Leukemic Cell Death via Caspase and DR5 Receptor-Dependent Pathways |
| Q34376039 | Mucin associated Tn and sialosyl-Tn antigen expression in colorectal polyps |
| Q41204090 | Mucin glycoproteins in neoplasia |
| Q35820342 | Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis |
| Q35978268 | Mucin-associated sialosyl-Tn antigen expression in gastric cancer correlates with an adverse outcome |
| Q34032146 | Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease |
| Q36592454 | Multifunctional nanobeacon for imaging Thomsen-Friedenreich antigen-associated colorectal cancer |
| Q33548177 | N-Acetylgalactosaminyltransferase-14 as a potential biomarker for breast cancer by immunohistochemistry |
| Q44027999 | Noninvasive colorectal cancer screening |
| Q57169347 | Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2-6 sialic acids |
| Q64261185 | O-glycans truncation modulates gastric cancer cell signaling and transcription leading to a more aggressive phenotype |
| Q39169405 | Overexpression of tumour-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours |
| Q35069229 | Overexpression of α2,3sialyl T-antigen in breast cancer determined by miniaturized glycosyltransferase assays and confirmed using tissue microarray immunohistochemical analysis |
| Q41594921 | Perspectives on the significance of altered glycosylation of glycoproteins in cancer |
| Q35584716 | Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancer |
| Q55284634 | Polypeptide-GalNAc-T6 expression predicts better overall survival in patients with colon cancer. |
| Q77662764 | Prognostic value of expression of sialosyl-Tn antigen in colorectal carcinoma and transitional mucosa |
| Q35413473 | Protein glycosylation in cancer |
| Q40849316 | Protein glycosylation in cancer biology: an overview |
| Q28069952 | Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma |
| Q38926234 | RNAi-mediated gene silencing of ST6GalNAc I suppresses the metastatic potential in gastric cancer cells |
| Q33593920 | Rectal mucosal quantitative galactose oxidase-Schiff reaction as an early detection biomarker for colorectal cancer: comparison to fecal occult stool blood test |
| Q27027559 | Regulation of the metastatic cell phenotype by sialylated glycans |
| Q33431143 | Resolving conflicting data on expression of the Tn antigen and implications for clinical trials with cancer vaccines |
| Q35535035 | Serum sialyl Lewis X-i antigen in lung adenocarcinoma and idiopathic pulmonary fibrosis |
| Q33649572 | Sialyl-tn in cancer: (how) did we miss the target? |
| Q35160084 | Sialyltransferases in cancer |
| Q53468077 | Simple mucin-type carbohydrate antigens (T, sialosyl-T, Tn and sialosyl-Tn) in breast carcinogenesis. |
| Q38366325 | Simple sugars to complex disease--mucin-type O-glycans in cancer |
| Q40950382 | Specific role of T and Tn tumor-associated antigens in adhesion between a human breast carcinoma cell line and a normal human breast epithelial cell line |
| Q37236636 | Specificity in cancer immunotherapy |
| Q47998013 | Specificity of human anti-carbohydrate IgG antibodies as probed with polyacrylamide-based glycoconjugates. |
| Q36133931 | Structural Characterization of Mucin O-Glycosylation May Provide Important Information to Help Prevent Colorectal Tumor Recurrence |
| Q41285973 | Structurally defined synthetic cancer vaccines: analysis of structure, glycosylation and recognition of cancer associated mucin, MUC-1 derived peptides |
| Q38670449 | Synthesis of a C‐Glycoside Analogue of sTn: An HIV‐ and Tumor‐Associated Antigen |
| Q41774931 | Synthesis of double C-glycoside analogue of sTn. |
| Q41809862 | Synthetic and Immunological Studies of sTn Derivatives Carrying 5-N-(p-Substituted Phenylacetyl)Sialic Acid for the Development of Effective Cancer Vaccines |
| Q33999425 | Targeting of T/Tn antigens with a plant lectin to kill human leukemia cells by photochemotherapy |
| Q38197051 | The Cosmc connection to the Tn antigen in cancer |
| Q28075448 | The Role of Sialyl-Tn in Cancer |
| Q34290892 | The chemistry and immunochemistry of blood group A, B, H, and Lewis antigens: past, present and future |
| Q38331320 | The human repertoire of antibody specificities against Thomsen-Friedenreich and Tn-carcinoma-associated antigens as defined by human monoclonal antibodies |
| Q34622638 | The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression |
| Q38121846 | Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers |
| Q36186712 | Tobacco mosaic virus as a new carrier for tumor associated carbohydrate antigens |
| Q43093172 | What makes cancer stem cell markers different? |
Search more.